Difficult cases in heart failure. Percutaneous transluminal septal myocardial ablation in the management of hypertrophic obstructive cardiomyopathy.
Hypertrophic cardiomyopathy is a complex genetic condition with a heterogeneous clinical course. Some patients remain asymptomatic throughout life while others develop one or more of the adverse clinical consequences including symptoms of congestive heart failure with exertional dyspnea and functional disability (usually with preserved left ventricular systolic function), atrial fibrillation, or sudden cardiac death. Because of this heterogenicity in the clinical presentations, management of patients with hypertrophic cardiomyopathy includes a wide range of pharmacologic therapies as well as invasive approaches. In recent years, nonsurgical catheter-based treatment of hypertrophic cardiomyopathy has been increasingly used in the management of a subset of these patients. The authors present a case of percutaneous transluminal septal myocardial ablation in a patient with hypertrophic cardiomyopathy who was symptomatic despite maximal medical treatment.
Feghali
Georges
G
Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Alaeddini
Jamshid
J
Ramee
Stephen
S
Ventura
Hector O
HO
D001281:Atrial Fibrillation / Q000175:diagnosis / Q000601:surgery; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000601:surgery*; D017115:Catheter Ablation; D025401:Echocardiography, Stress; D004562:Electrocardiography; D006333:Heart Failure / Q000175:diagnosis / Q000601:surgery*; D006346:Heart Septum / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology*